957121-35-6

Basic information

• Product Name: CarbaMic acid, N-[(2S)-1,1',2',3-tetrahydro-2'-oxo-1'-[[2-(triMethylsilyl)ethoxy]Methyl]spiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, 1,1-diMethylethyl ester
• Synonyms: CarbaMic acid, N-[(2S)-1,1',2',3-tetrahydro-2'-oxo-1'-[[2-(triMethylsilyl)ethoxy]Methyl]spiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, 1,1-diMethylethyl ester;(S)-tert-butyl (2-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,1,2,3-tetrahydrospiro[indene-2,3-pyrrolo[2,3-b]pyridin]-5-yl)carbamate
• CAS NO: 957121-35-6
• Molecular Formula: C26H35N3O4Si
• Molecular Weight: 481.6593
• Mol File: 957121-35-6.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 577.5±50.0 °C(Predicted)
• Appearance: /
• Density: 1.19±0.1 g/cm3(Predicted)
• PKA: 13.77±0.20(Predicted)
• CAS DataBase Reference: CarbaMic acid, N-[(2S)-1,1',2',3-tetrahydro-2'-oxo-1'-[[2-(triMethylsilyl)ethoxy]Methyl]spiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: CarbaMic acid, N-[(2S)-1,1',2',3-tetrahydro-2'-oxo-1'-[[2-(triMethylsilyl)ethoxy]Methyl]spiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, 1,1-diMethylethyl ester(957121-35-6)
• EPA Substance Registry System: CarbaMic acid, N-[(2S)-1,1',2',3-tetrahydro-2'-oxo-1'-[[2-(triMethylsilyl)ethoxy]Methyl]spiro[2H-indene-2,3'-[3H]pyrrolo[2,3-b]pyridin]-5-yl]-, 1,1-diMethylethyl ester(957121-35-6)

Safety Data

• Hazardous Substances Data: 957121-35-6(Hazardous Substances Data)

Upstream product

• 76513-69-4 (2-trimethylethylsilylethoxy)methyl chloride 
• 22162-19-2 (4-nitro-1,2-phenylene)dimethanol 
• 610-27-5 4-nitrophthalic acid 
• 6425-66-7 1,2-bis-bromomethyl-4-nitro-benzene 
• 879132-50-0 5-amino-1‘-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydrospiro[indene-2,3’-pyrrolo[2,3-b]pyridin]-2’(1’H)-one 
• 879132-49-7 5-nitro-1‘-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydrospiro[indene-2,3’-pyrrolo[2,3-b]pyridin]-2’(1’H)-one 
• 879132-47-5 3,3-dibromo-1-{[2-(trimethylsilyl)ethoxy]methyl}-1,3-dihydro-2H-pyrrolo[2.3-b]pyridin-2-one 
• 879132-48-6 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one 
• 271-63-6 7-Azaindole 
• 879132-46-4 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine 
• 1033608-31-9 tert-butyl (+/-)-(2'-oxo-1'-{[2-(trimethylsilyl)ethoxy]methyl}-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)carbamate 
• 24424-99-5 di-tert-butyl dicarbonate 

Relevant articles and documents

IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS

The present invention is directed to imidazolinone derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical comp

MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS

The present invention is directed to compounds of Formula I: I (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors an

CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS

Compounds of formula I: (I) (wherein variables A, m, n, J, Re, Rf, R4, Ea, Eb, Ec, RPG and Y are as described herein) which are antagonists of CGRP receptors and which are useful